EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered Nanobodies for early and accurate diagnosis of dengue virus infection

María Florencia Pavan, Cristian Miguel Malnero, María Emilia Mora Alvarado, María Camila Carzoglio, Yesica Paredes Rojas, Agostina Bruno, Laura Perez Vidakovics, Leo Hanke, Alejandro Castello, Gerald McInerney, Cybele Carina García, Viviana Parreño und 1 weitere

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0013168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von María Florencia Pavan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Ingeniería de Anticuerpos. Instituto de Química Física de los Materiales, Medio Ambiente y Energía (INQUIMAE), Universidad de Buenos A…. Hauptthemen laut MEDLINE: Dengue, Dengue Virus, Antibodies, Viral, Single-Domain Antibodies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación, Ministerio de Ciencia, Tecnología e Innovación, Agencia Nacional de Promoción CientÃfica y Tecnológica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Dengue virus (DENV), a mosquito-borne flavivirus responsible for dengue disease, has emerged as an escalating global health concern, with cases increasing sharply in recent decades. In Argentina, dengue has transitioned from a sporadic disease to a recurrent epidemic, now affecting 18 of 23 provinces and exposing gaps in diagnostic capacity. Methodology and Principal Findings The DENV genome encodes the non-structural protein 1 (NS1), a key biomarker for early infection detection. Given the limited access to commercially available diagnostic kits within the public health system, we developed a combined ELISA system incorporating Nanobodies designed to target NS1 across all four DENV serotypes as detection antibodies. This system demonstrates excellent discriminative performance (AUC > 0.9), with a diagnostic sensitivity of 93.6% (95% CI: 86.6–97.6%) and a specificity of 81.1% (95% CI: 70.3–89.3%). The analytical sensitivity showed strong correlation between sera pool dilutions and detected signals, with a limit of detection aligning with reported NS1 concentrations in human samples. While the system exhibits limitations in detecting NS1 from DENV-4, it successfully identified cases in patients five days post-symptom onset who were initially considered epidemiologically negative for dengue infection. Significance Our results underscore the urgent need for accessible, high-precision diagnostic tools in regions facing a surge in dengue outbreaks. Additionally, they highlight the necessity of revising current diagnostic algorithms to enhance the detection of late-presenting cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DengueDengue VirusAntibodies, ViralSingle-Domain AntibodiesHumansEnzyme-Linked Immunosorbent AssayViral Nonstructural ProteinsSensitivity and SpecificityEarly DiagnosisArgentinaAnimals

Substanzen

Antibodies, ViralViral Nonstructural ProteinsSingle-Domain Antibodies

Autor:innen und Institutionen

  • Laboratorio de Ingeniería de Anticuerpos. Instituto de Química Física de los Materiales, Medio Ambiente y Energía (INQUIMAE), Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONI…
  • Centro de Virología Humana y Animal (CEVHAN), Instituto de Ciencia y Tecnología Dr. César Milstein, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires, Argentina.
  • Laboratorio de Inmunología y Virología. Instituto de Microbiología Básica y Aplicada. Departamento de Ciencia y Tecnología. Universidad Nacional de Quilmes. (UNQUI), Buenos Aires, Argentina.
  • Hospital San Vicente de Paul, Laboratorio de Enfermedades Tropicales. Orán, Salta, Argentina.
  • Division of Virology and Immunology, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Laboratorio de Estrategias Antivirales. Departamento de Química Biológica (QB), Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires, Argenti…

ORCID-Profile: Lorena Itatí Ibañez

Förderung

  • Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación
  • Ministerio de Ciencia, Tecnología e Innovación
  • Agencia Nacional de Promoción CientÃfica y Tecnológica
  • Ministerio de Ciencia, TecnologÃa e Innovación

Zitieren

APA

Pavan, M. F., Malnero, C. M., Mora Alvarado, M. E., Carzoglio, M. C., Rojas, Y. P., Bruno, A., Vidakovics, L. P., Hanke, L., Castello, A., McInerney, G., García, C. C., Parreño, V., & Ibañez, L. I. (2025). Engineered Nanobodies for early and accurate diagnosis of dengue virus infection. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013168

Vancouver

Pavan MF, Malnero CM, Mora Alvarado ME, Carzoglio MC, Rojas YP, Bruno A, et al. Engineered Nanobodies for early and accurate diagnosis of dengue virus infection. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013168

BibTeX
@article{Pavan2025,
  author = {Pavan, María Florencia and Malnero, Cristian Miguel and Mora Alvarado, María Emilia and Carzoglio, María Camila and Rojas, Yesica Paredes and Bruno, Agostina and Vidakovics, Laura Perez and Hanke, Leo and Castello, Alejandro and McInerney, Gerald and García, Cybele Carina and Parreño, Viviana and Ibañez, Lorena Itatí},
  title = {Engineered Nanobodies for early and accurate diagnosis of dengue virus infection},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0013168}
}
Kostenlos starten →